Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Bioidentical progesterone is a hormone supplement identical in molecular structure to naturally produced progesterone, primarily acting through progesterone receptor binding to regulate reproductive and neurological functions. It balances estrogen levels, supports mood stability through GABA receptor modulation, and promotes bone health by stimulating osteoblast activity.
Reported Benefits (Provisional)
Origin & History
Bioidentical progesterone is a hormone identical in molecular structure to the progesterone produced by the human body. It is typically synthesized from plant sources like soy or wild yam.
Research Narrative (Provisional)
Numerous studies support its use in hormone replacement therapy, with RCTs demonstrating efficacy in reducing menopausal symptoms and improving bone health.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Identical to naturally occurring progesterone in the body. - Used in hormone replacement therapy for menopausal symptoms. - Available in oral, topical, and injectable forms.
Reported Mechanism (Provisional)
Bioidentical progesterone binds to progesterone receptors (PR-A and PR-B) in target tissues, regulating gene transcription and protein synthesis. It modulates GABA-A receptors in the brain to produce calming effects and counteracts estrogen's proliferative effects by promoting secretory endometrial changes. Additionally, it stimulates osteoblast activity while inhibiting osteoclast function through direct receptor-mediated pathways.
Clinical Narrative (Provisional)
Clinical trials demonstrate bioidentical progesterone reduces PMS symptoms by up to 50% compared to placebo in randomized controlled studies of 200-400 women. Mood improvement studies show significant anxiety reduction with 200-400mg daily doses over 8-12 week periods. Bone density research indicates 2-3% annual improvement in postmenopausal women using progesterone therapy. However, long-term safety data remains limited compared to synthetic progestins.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.